Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss
Clinical benefit again observed for OTO-413 versus placebo for multiple efficacy endpoints based on responder…
Year: 2022
Reduction of share capital
Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital
Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious Disease
–94% cumulative protective effect against COVID-19 in previously-infected individuals that subsequently received Clover’s COVID-19 vaccine…
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
– 356 IPF Patients Enrolled – – Topline Data Anticipated Mid-2023 – SAN FRANCISCO, April…
Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience
LOS ANGELES, April 20, 2022 (GLOBE NEWSWIRE) — Enochian BioSciences (NASDAQ: ENOB). Enochian BioSciences Inc.,…
Tonix Pharmaceuticals Announces Results of Retrospective Observational Database Study In Over 50,000 Long COVID Patients
Over 40% of Long COVID Patients Had Fibromyalgia-Like Multi-Site Pain Symptoms Rate of Opioid Use…
Trevena Announces Results from Respiratory Physiology Study of Head-to-Head Comparison of OLINVYK® and IV Morphine in Elderly/Overweight Subjects
OLINVYK showed a statistically significant reduced impact on respiratory function compared to IV morphine, among…
Vistin Pharma ASA: Invitation to Q1 2022 conference call
Oslo, Norway, 20 April 2022 Vistin Pharma ASA will release its first quarter 2022 results…
COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers
London, UK – 20 April 2022 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental…
Oxford Biomedica Preliminary Results
Oxford Biomedica plcPreliminary results for the year ended 31 December 2021 Saving Lives Oxford, UK…
XORTX Receives Small and Medium Enterprise Status for the European Union
CALGARY, Alberta, April 20, 2022 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…
HOOKIPA Pharma Appoints Tim Reilly, Ph.D. to its Board of Directors
NEW YORK and VIENNA, Austria, April 20, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
Windtree Announces Positive Topline Results from Its Phase 2 SEISMiC Study of Istaroxime in Early Cardiogenic Shock
Istaroxime significantly improved the systolic blood pressure profile WARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE)…
VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders
Zachary Carpenter Zachary Carpenter, Ph.D., Founder and CEO of VantAI VantAI will pair its induced…
Leading Decentralized Exchange, AscendEX Lists MetaShooter ($MHUNT)
SINGAPORE, April 20, 2022 (GLOBE NEWSWIRE) — Today, AscendEX is excited to announce the listing…
Cloudbeds Releases New Guide For Future-Proofing Every Type of Lodging Business
Expert team behind leading hotel technology platform unlocks industry insights to empower owners and operators…
StrikeForce Begins Process to Become HIPAA Compliant as it Continues to See Demand Surge in Healthcare
EDISON, N.J., April 20, 2022 (GLOBE NEWSWIRE) — StrikeForce Technologies, Inc. (OTCQB: SFOR), a cyber…
Amdocs’ Vubiquity Unveils MetaVU, Simplifying Metadata Aggregation and Industry Pain Points
MetaVU provides a high-value, low investment approach to metadata management, enabling a rich, unified consumer…
ListenFirst Announces ListenFirst University, An Immersive Social Analytics Training Solution
The interactive learning management system offers on-demand training to marketers looking to master social analytics….
Runiverse: Elite Token Launches Its First Play2Earn Game
Miami, Florida–(Newsfile Corp. – April 20, 2022) – Elite Token, being one of the most…